For the Inventor, By the Inventor

Enter inventor name

Hong Luo

USPTO Granted Patents = 17 (Patent Applications = 1)

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 9 (Patent Applications = 14)

Average Co-Inventor Count = 9.0

ph-index = 5

Forward Citations = 61(Granted Patents)

Company Filing History:

Centaurus Biopharma Co., Ltd.

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Lianyungang Runzhong Pharmaceutical Co., Ltd.

4. 1 out of 5,002

Centaurus Biophrama Co., Ltd.

6. 1 out of 116

University of Science and Technology Beijing

where one patent can have more than one assignee

Years Active: 2016-2023

where 'Filed Patents' based on already Granted Patents

17 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11555778 - High-flux sensor suitable for corrosion big data monitoring and manufacturing method (2023-01-17),

2. 10829492 - Amino pyrazolopyrimidine compound used as neurotrophic factor tyrosine kinase receptor inhibitor (2020-11-10),

3. 10745383 - 1,3,5-triazine derivative and method of using same (2020-08-18),

4. 10732943 - Programming model of neural network-oriented heterogeneous computing platform (2020-08-04),

5. 10617692 - Pyrrolopyrimidine comprising cyclopentyl substituent (2020-04-14),

6. 10570141 - Substituted pyrrolopyrimidine CDK inhibitor, pharmaceutical composition containing same and use thereof (2020-02-25),

7. 10561657 - Pyrrolopyrimidine compound (2020-02-18),

8. 10329277 - N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(3-methyl-2-OXO-2,3-dihydro-1h-benzo[d]imidazol-1-yl)pyrimidin-2-yl)amino)phenyl)acrylamide hydrochloride as an inhibitor of epidermal growth factor receptor activity (2019-06-25),

9. 10155775 - Substituted amino six-membered saturated heteroalicycles as long-acting DPP-IV inhibitors (2018-12-18),

10. 10155722 - Antitumor compound targeting IDH2 mutation and method of use thereof (2018-12-18),

11. 10112922 - Inhibitor of bruton's tyrosine kinase (2018-10-30),

12. 9926299 - Inhibitors of bruton's tyrosine kinase (2018-03-27),

13. 9725439 - Quinazoline derivative and preparation method therefor (2017-08-08),

14. 9708295 - Substituted 2-aminopyridine protein kinase inhibitor (2017-07-18),

15. 9550781 - Kinase modulating compounds, compositions containing the same and use thereof (2017-01-24),

Title: Inventor Hong Luo - Revolutionizing Technology in Beijing

Introduction: Hong Luo is a visionary inventor based in Beijing, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Hong Luo holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing his commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Hong Luo has worked with leading tech companies and research institutions, playing a pivotal role in developing cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Hong Luo has collaborated with top engineers, scientists, and researchers from around the world, fostering a culture of innovation and knowledge exchange to drive progress in the tech sector.

Conclusion: Hong Luo's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and technologists, solidifying his legacy as a true pioneer in the field of technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…